Friday, 29 August 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 29 August 2025
News

'Frustrated and confused' by PBAC

 Posted 26 August 2025 AM

Rare Cancers Australia has joined the growing pushback against the PBAC, expressing frustration and confusion over its failure to act on a multi-cancer funding model.

It follows a decision by the Committee to reject an application by MSD for a broad listing for all TGA-registered indications for its blockbuster drug Keytruda, pointing out the model would exclude some patients with rare cancers.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (12)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (6)

Other (14)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.